Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Aurinia’s Response to COVID-19

View

Latest News

August 4, 2020 • 12:00am EDT

Aurinia Pharmaceuticals to Present at the BTIG Virtual Biotechnology Conference

Read Press Release View All News

July 30, 2020 • 12:00am EDT

Aurinia Pharmaceuticals to Report Second Quarter 2020 Financial Results on August 11, 2020

Read Press Release View All News

July 27, 2020 • 12:00am EDT

Aurinia Closes US$200 Million Public Offering of Common Shares

Read Press Release View All News